BA.5 sub-variant can re-infect you with Covid 'within weeks': Experts

The BA.5 Omicron, which is known to evade immunity induced both by vaccines as well as prior infection, has the potential to reinfect you with Covid again "within weeks", global researchers

coronavirus
Photo by Viktor Forgacs on Unsplash
IANS New Delhi
2 min read Last Updated : Jul 11 2022 | 7:05 PM IST

The BA.5 Omicron sub-variant, which is known to evade immunity induced both by vaccines as well as prior infection, has the potential to reinfect you with Covid again "within weeks", global researchers have said.

BA.5, together with BA.4 and other sub-variants, are said to be behind the current surge in infections seen in a slew of countries including India, China, US, and European nations, notably the UK and Italy.

It has been a common assumption during the pandemic that being infected with a Covid variant provides a natural immune boost, enabling one's immune system to better recognise and fend off infection in the future.

However, Omicron BA.5 proves to be different, with several researchers terming it as "the most easily transmissible Covid variant to date".

"The main reason this variant has become the predominant one that is now circulating is that it is able to evade previous immunity," said Dean Blumberg, chief of Paediatric Infectious Diseases at University of California, Davis, Children's Hospital. "Even people who have partial immunity from a previous infection or vaccination can still have a breakthrough infection."

That means even if you were infected in 2020 with Delta or even Omicron BA.1 last winter, you can still get BA.5. Your previous immunity does not protect you from the latest strain.

"What we are seeing is an increasing number of people who have been infected with BA.2 and then becoming infected after four weeks," Andrew Roberston, the chief health officer in Western Australia, was quoted as saying to News.com.au.

"So maybe six to eight weeks they are developing a second infection, and that's almost certainly BA.4 or BA.5," he added.

This may be explained by a recent study, published in the journal Science, which showed that Omicron provides a poor natural boost of Covid immunity against reinfection even with Omicron and also in people who are triple-vaccinated.

Researchers at the Imperial College London called the BA.5 "an especially stealthy immune evader".

"Not only can it break through vaccine defences, it looks to leave very few of the hallmarks we'd expect on the immune system - it's more stealthy than previous variants and flies under the radar, so the immune system is unable to remember it," said Professor Danny Altmann, from Department of Immunology and Inflammation at Imperial.

--IANS

rvt/vd

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

First Published: Jul 11 2022 | 7:05 PM IST

Next Story